GlassScriptPhysician profile
Andrew Mikeska
NPI 1760975049
$6,829.02
in general payments reported to CMS, 2019-2025
12 companies · $349 in 2025
The $349 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
See the full distribution for Orthopaedic Surgery of the Spine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $94.30 · 2022: $353 · 2023: $1,929 · 2024: $4,104 · 2025: $349.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,587 · Food and Beverage: $1,795.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,586.50 |
| Food and Beverage | $1,795.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Synthes Gmbh | $2,790.73 | 2023-2024 | |
| Alphatec Spine, INC | $1,952.91 | 2023-2025 | Other - Miscellaneous |
| Depuy Synthes Sales INC. | $833.68 | 2023-2025 | Teligen, Conduit, Expedium Verse |
| Stryker Corporation | $353.22 | 2022 | |
| Globus Medical, INC. | $345.79 | 2023-2024 | Excelsius3d Imaging System, Caliber L, Distal Femur Plate System |
| Abbott Laboratories | $168.87 | 2025 | Proclaim |
| Si-Bone, INC. | $156.48 | 2024 | |
| Heron Therapeutics, INC. | $94.30 | 2021 | |
| Medical Device Business Services, INC. | $46.51 | 2024 | Teligen |
| Bioventus LLC | $36.38 | 2023 | Exogen Ultrasound Bone Healing System |
| Smith+Nephew, INC. | $28.40 | 2023-2024 | Stravix |
| Orthofix Medical, INC. | $21.75 | 2023 | Physio-Stim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Mikeska listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.